GeneDx (WGS) - Margin dodolan resik

Tandha merek Sema4 (WGS)

Demand for the early detection of rare pathologies is driving industry growth. GeneDx Holdings Corp. (WGS) generates revenue through high-precision whole-exome sequencing and molecular diagnostics. Meanwhile, business profitability relies on AI implementation and the scaling of test volumes. Net margin dynamics demonstrate effective cost control, and the -24.10 metric reflects the company's current sales profitability trend.

Margin dodolan perusahaan genedx.com (WGS): kanggo periode 28.04.2023 - 20.11.2026

Rincian analitis lan laporan data perusahaan GeneDx Corp (WGS)

- nilai pasar lan prakiraan target analis:
Analisis komprehensif perusahaan:GeneDx Holdings Corp.
Barang unggulan Sema4

GeneDx Holdings Corp. (WGS) leadership in genomic sequencing and its unique exome database should translate into high efficiency, as reflected by the net profit margin. This indicator measures the portion of profit in every dollar of revenue, demonstrating the business's ability to maintain profitability under pessimistic scenarios. A decline in this metric signals a loss of financial strength, making the purchase of shares risky.

Karo sapa GeneDx Holdings Corp. saingan

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|Margin resik Ultragenyx RARE|Margin dodolan perusahaan Beam Therapeutics (BEAM)|SRPT: Rentabilitas dodolan miturut bathi resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX